| scholarly article | Q13442814 |
| P50 | author | Douglas L. Mann | Q51140505 |
| P2093 | author name string | James A Thomas | |
| Jesus G Vallejo | |||
| Huei-Ping Tzeng | |||
| Jian-Wen Dong | |||
| P2860 | cites work | Phylogenetic perspectives in innate immunity | Q28144345 |
| TIRAP: an adapter molecule in the Toll signaling pathway | Q28214613 | ||
| Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components | Q28511151 | ||
| The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors | Q28511605 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| Innate immunity: the virtues of a nonclonal system of recognition | Q29614428 | ||
| Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function | Q33288891 | ||
| Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium | Q33853586 | ||
| Alarmins: chemotactic activators of immune responses | Q36162859 | ||
| Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice | Q36893375 | ||
| Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury | Q36955913 | ||
| Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart | Q37088298 | ||
| The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors. | Q39985197 | ||
| Effect of rottlerin, a PKC-delta inhibitor, on TLR-4-dependent activation of murine microglia | Q40369379 | ||
| The extra domain A of fibronectin activates Toll-like receptor 4. | Q40832345 | ||
| Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes | Q42496147 | ||
| Tumor necrosis factor and viral myocarditis: the fine line between innate and inappropriate immune responses in the heart | Q43691551 | ||
| Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits | Q44350297 | ||
| IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity | Q44916776 | ||
| Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism | Q46759088 | ||
| Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice | Q47200145 | ||
| Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining | Q47314308 | ||
| Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. | Q47341057 | ||
| Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia | Q47929295 | ||
| Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. | Q50501539 | ||
| Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. | Q54534373 | ||
| Involvement of PKCα/β in TLR4 and TLR2 dependent activation of NF-κB | Q57359987 | ||
| Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury | Q57374682 | ||
| Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction | Q59981285 | ||
| Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics | Q71763127 | ||
| Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit Hearts | Q71974392 | ||
| Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits | Q73278997 | ||
| HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine | Q73606601 | ||
| LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha | Q73856660 | ||
| Seeing death in the living | Q77301326 | ||
| Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury | Q79839081 | ||
| Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction | Q79856753 | ||
| Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart | Q80392200 | ||
| Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury | Q83918073 | ||
| P433 | issue | 3 | |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | H1079-87 | |
| P577 | publication date | 2010-01-08 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways | |
| P478 | volume | 298 |
| Q36456832 | CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling |
| Q42157765 | Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach |
| Q34357976 | Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling |
| Q37141047 | Distinct effects of inflammation on preconditioning and regeneration of the adult zebrafish heart |
| Q52353228 | Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage. |
| Q42144631 | Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathway |
| Q98226408 | Innate Immune Receptors, Key Actors in Cardiovascular Diseases |
| Q38250327 | Innate immune receptors in heart failure: Side effect or potential therapeutic target? |
| Q90700337 | Innate immunity as a target for acute cardioprotection |
| Q28082430 | Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor |
| Q101390654 | Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway |
| Q37854080 | Role of toll-like receptors in cardiovascular diseases |
| Q37772401 | TLR2 and TLR4 in ischemia reperfusion injury |
| Q34062721 | TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism |
| Q38875774 | The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. |
| Q37870040 | The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls |
| Q37977824 | The innate immune response in reperfused myocardium |
| Q37809215 | Therapeutic targeting of innate immunity in the failing heart |
| Q34605156 | Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms. |
| Q38053492 | Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities |
| Q37850809 | Toll-like receptors as potential therapeutic targets in cardiac dysfunction |
| Q37810952 | Toll-like receptors: new players in myocardial ischemia/reperfusion injury |
Search more.